BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34695156)

  • 1. SARS-CoV-2 infection in central North Carolina: Protocol for a population-based longitudinal cohort study and preliminary participant results.
    Miller EM; Law EA; Ajeen R; Karasik J; Mendoza C; Abernathy H; Garrett H; King E; Wallace J; Zelek M; Edwards JK; Xiong K; Beatty C; Fleischauer AT; Ciccone EJ; Shook-Sa BE; Aiello AE; Boyce RM
    PLoS One; 2021; 16(10):e0259070. PubMed ID: 34695156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.
    Harvey RA; Rassen JA; Kabelac CA; Turenne W; Leonard S; Klesh R; Meyer WA; Kaufman HW; Anderson S; Cohen O; Petkov VI; Cronin KA; Van Dyke AL; Lowy DR; Sharpless NE; Penberthy LT
    JAMA Intern Med; 2021 May; 181(5):672-679. PubMed ID: 33625463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
    Pardo Lledias J; Ayarza L; González-García P; Salmón González Z; Calvo Montes J; Gozalo Marguello M; Hernández Hernández JL; Olmos Martínez JM
    Rev Esp Quimioter; 2020 Dec; 33(6):410-414. PubMed ID: 32935535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership.
    Williamson JC; Wierzba TF; Santacatterina M; Munawar I; Seals AL; Pittman Ballard CA; Alexander-Miller M; Runyon MS; McCurdy LH; Gibbs MA; Ahmed A; Lagarde WH; Maguire PD; King-Thiele R; Hamrick T; Ihmeidan A; Henderson S; Gallaher TR; Uschner D; Edelstein SL; Herrington DM; Sanders JW;
    PLoS One; 2022; 17(3):e0260574. PubMed ID: 35302997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of SARS-CoV-2 Infection Among Health Care Workers in a Tertiary Community Hospital.
    Jeremias A; Nguyen J; Levine J; Pollack S; Engellenner W; Thakore A; Lucore C
    JAMA Intern Med; 2020 Dec; 180(12):1707-1709. PubMed ID: 32780100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.
    Ferreira VH; Chruscinski A; Kulasingam V; Pugh TJ; Dus T; Wouters B; Oza A; Ierullo M; Ku T; Majchrzak-Kita B; Humar ST; Bahinskaya I; Pinzon N; Zhang J; Heisler LE; Krzyzanowski PM; Lam B; Lungu IM; Manase D; Pace KM; Mashouri P; Brudno M; Garrels M; Mazzulli T; Cybulsky M; Humar A; Kumar D
    PLoS One; 2021; 16(2):e0247258. PubMed ID: 33592074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
    Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
    Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological Testing Reveals the Hidden COVID-19 Burden among Health Care Workers Experiencing a SARS-CoV-2 Nosocomial Outbreak.
    Nakagama Y; Komase Y; Candray K; Nakagama S; Sano F; Tsuchida T; Kunishima H; Imai T; Shintani A; Nitahara Y; Kaku N; Kido Y
    Microbiol Spectr; 2021 Oct; 9(2):e0108221. PubMed ID: 34550021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area.
    Lindan CP; Desai M; Boothroyd D; Judson T; Bollyky J; Sample H; Weng Y; Cheng Y; Dahlen A; Hedlin H; Grumbach K; Henne J; Garcia S; Gonzales R; Craik CS; Rutherford G; Maldonado Y
    Ann Epidemiol; 2022 Mar; 67():81-100. PubMed ID: 34800659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of asymptomatic SARS-CoV-2 infection in elective surgical patients in Australia: a prospective surveillance study.
    Coatsworth N; Myles PS; Mann GJ; Cockburn IA; Forbes AB; Gardiner EE; Lum G; Cheng AC; Gruen RL;
    ANZ J Surg; 2021 Jan; 91(1-2):27-32. PubMed ID: 33421257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.
    Tang X; Sharma A; Pasic M; Brown P; Colwill K; Gelband H; Birnboim HC; Nagelkerke N; Bogoch II; Bansal A; Newcombe L; Slater J; Rodriguez PS; Huang G; Fu SH; Meh C; Wu DC; Kaul R; Langlois MA; Morawski E; Hollander A; Eliopoulos D; Aloi B; Lam T; Abe KT; Rathod B; Fazel-Zarandi M; Wang J; Iskilova M; Pasculescu A; Caldwell L; Barrios-Rodiles M; Mohammed-Ali Z; Vas N; Santhanam DR; Cho ER; Qu K; Jha S; Jha V; Suraweera W; Malhotra V; Mastali K; Wen R; Sinha S; Reid A; Gingras AC; Chakraborty P; Slutsky AS; Jha P;
    JAMA Netw Open; 2022 Feb; 5(2):e2146798. PubMed ID: 35171263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers.
    Heffernan E; Kennedy L; Hannan MM; Ramlaul N; Denieffe S; Courtney G; Watt A; Hurley J; Lynch M; Fitzgibbon M
    Ann Clin Biochem; 2021 Sep; 58(5):496-504. PubMed ID: 33845592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
    Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
    Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study.
    Waterfield T; Watson C; Moore R; Ferris K; Tonry C; Watt A; McGinn C; Foster S; Evans J; Lyttle MD; Ahmad S; Ladhani S; Corr M; McFetridge L; Mitchell H; Brown K; Amirthalingam G; Maney JA; Christie S
    Arch Dis Child; 2021 Jul; 106(7):680-686. PubMed ID: 33172887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020.
    Lopez CA; Cunningham CH; Pugh S; Brandt K; Vanna UP; Delacruz MJ; Guerra Q; Bhowmik DR; Goldstein SJ; Hou YJ; Gearhart M; Wiethorn C; Pope C; Amditis C; Pruitt K; Newberry-Dillon C; Schmitz JL; Premkumar L; Adimora AA; Baric RS; Emch M; Boyce RM; Aiello AE; Fosdick BK; Larremore DB; de Silva AM; Juliano JJ; Markmann AJ
    mSphere; 2022 Jun; 7(3):e0084121. PubMed ID: 35587682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
    Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM
    Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
    Matta J; Wiernik E; Robineau O; Carrat F; Touvier M; Severi G; de Lamballerie X; Blanché H; Deleuze JF; Gouraud C; Hoertel N; Ranque B; Goldberg M; Zins M; Lemogne C;
    JAMA Intern Med; 2022 Jan; 182(1):19-25. PubMed ID: 34747982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.